246 related articles for article (PubMed ID: 28631805)
21. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
22. Oxcarbazepine for neuropathic pain.
Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
[TBL] [Abstract][Full Text] [Related]
23. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy.
Chalk C; Benstead TJ; Moore F
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD004572. PubMed ID: 17943821
[TBL] [Abstract][Full Text] [Related]
24. Chronic axonal idiopathic polyneuropathy: is it really benign.
Samuelsson K; Press R
Curr Opin Neurol; 2020 Oct; 33(5):562-567. PubMed ID: 32773448
[TBL] [Abstract][Full Text] [Related]
25. Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol.
Kopsky DJ; van Eijk RPA; Warendorf JK; Keppel Hesselink JM; Notermans NC; Vrancken AFJE
Trials; 2022 Oct; 23(1):888. PubMed ID: 36273216
[TBL] [Abstract][Full Text] [Related]
26. Chronic idiopathic axonal polyneuropathy: Prevalence of pain and impact on quality of life.
Zis P; Sarrigiannis PG; Rao DG; Hewamadduma C; Hadjivassiliou M
Brain Behav; 2019 Jan; 9(1):e01171. PubMed ID: 30474238
[TBL] [Abstract][Full Text] [Related]
27. Performance and Self-reported Functioning of People With Chronic Idiopathic Axonal Polyneuropathy: A 4-Year Follow-up Study.
van Oeijen K; Teunissen LL; van Leeuwen C; van Opstal M; José van der Putten M; Notermans NC; van Meeteren NLU; Schröder CD
Arch Phys Med Rehabil; 2020 Nov; 101(11):1946-1952. PubMed ID: 32682939
[TBL] [Abstract][Full Text] [Related]
28. Chronic idiopathic axonal polyneuropathy: Electrophysiological progression and human leukocyte antigen associations.
Zis P; Sarrigiannis PG; Artemiadis A; Skarlatou V; Hadjivassiliou M
Muscle Nerve; 2021 Apr; 63(4):567-571. PubMed ID: 33440030
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy for idiopathic lumbosacral plexopathy.
van Eijk J; Chan YC; Russell JW
Cochrane Database Syst Rev; 2013 Dec; (12):CD009722. PubMed ID: 24379134
[TBL] [Abstract][Full Text] [Related]
30. Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome.
Visser NA; Vrancken AF; van der Schouw YT; van den Berg LH; Notermans NC
Diabetes Care; 2013 Apr; 36(4):817-22. PubMed ID: 23204246
[TBL] [Abstract][Full Text] [Related]
31. RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy.
Tagliapietra M; Cardellini D; Ferrarini M; Testi S; Ferrari S; Monaco S; Cavallaro T; Fabrizi GM
J Neurol; 2021 Nov; 268(11):4280-4290. PubMed ID: 33884451
[TBL] [Abstract][Full Text] [Related]
32. RFC1 expansions are a common cause of idiopathic sensory neuropathy.
Currò R; Salvalaggio A; Tozza S; Gemelli C; Dominik N; Galassi Deforie V; Magrinelli F; Castellani F; Vegezzi E; Businaro P; Callegari I; Pichiecchio A; Cosentino G; Alfonsi E; Marchioni E; Colnaghi S; Gana S; Valente EM; Tassorelli C; Efthymiou S; Facchini S; Carr A; Laura M; Rossor AM; Manji H; Lunn MP; Pegoraro E; Santoro L; Grandis M; Bellone E; Beauchamp NJ; Hadjivassiliou M; Kaski D; Bronstein AM; Houlden H; Reilly MM; Mandich P; Schenone A; Manganelli F; Briani C; Cortese A
Brain; 2021 Jun; 144(5):1542-1550. PubMed ID: 33969391
[TBL] [Abstract][Full Text] [Related]
33. Peripheral polyneuropathy from electrodiagnostic tests: a 10-year etiology and neurophysiology overview.
Ducci RD; Tessaro CL; Kay CSK; Fustes OJH; Werneck LC; Lorenzoni PJ; Scola RH
Arq Neuropsiquiatr; 2022 Mar; 80(3):270-279. PubMed ID: 34816968
[TBL] [Abstract][Full Text] [Related]
34. Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review.
Samuelsson K; Press R
Front Neurol; 2018; 9():43. PubMed ID: 29483890
[TBL] [Abstract][Full Text] [Related]
35. Diet quality and chronic axonal polyneuropathy: a population-based study.
Taams NE; Voortman T; Hanewinckel R; Drenthen J; van Doorn PA; Ikram MA
Ann Clin Transl Neurol; 2019 Dec; 6(12):2460-2467. PubMed ID: 31738024
[TBL] [Abstract][Full Text] [Related]
36. Rituximab Treatment for Chronic Idiopathic Axonal Polyneuropathy.
Moussa H; Sawaya RA
J Clin Neuromuscul Dis; 2021 Jun; 22(4):214-219. PubMed ID: 34019006
[TBL] [Abstract][Full Text] [Related]
37. [Rehabilitation methods for cancer patients with peripheral polyneuropathy induced by cytostatics].
Grushina TI; Konchugova TV; Kulchitskaya DB; Gushchina NV; Astakhova KA
Vopr Kurortol Fizioter Lech Fiz Kult; 2021; 98(1):58-63. PubMed ID: 33605131
[TBL] [Abstract][Full Text] [Related]
38. Vitamin B6 levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy.
Stewart SL; Thomas S; Höke E; Simpson D; Singleton JR; Höke A
J Peripher Nerv Syst; 2022 Mar; 27(1):31-37. PubMed ID: 34931740
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and Risk Factor Profiles for Chronic Axonal Polyneuropathy in the General Population.
Taams NE; Drenthen J; Hanewinckel R; Ikram MA; van Doorn PA
Neurology; 2022 Nov; 99(20):e2234-e2240. PubMed ID: 36008153
[TBL] [Abstract][Full Text] [Related]
40. Effect of strength training on functional outcomes and strength in patients with polyneuropathy: A scoping review.
Pedersen BS; Kodal LS; Kaalund AB; Holm-Yildiz S; Pedersen MM; Dysgaard T
Front Physiol; 2023; 14():1158039. PubMed ID: 37089431
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
